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Background: Cases of Mycobacterium bovis infection South American camelids have been increasing in Great
Britain. Current antemortem immunological tests have some limitations. Cases at post mortem examination
frequently show extensive pathology. The feasibility of detecting Mycobacterium bovis DNA in clinical samples was
investigated.
Findings: A sensitive extraction methodology was developed and used on nasal swabs and faeces taken
post-mortem to assess the potential for a PCR test to detect Mycobacterium bovis in clinical samples. The gross
pathology of the studied South American camelids was scored and a significantly greater proportion of South
American camelids with more severe pathology were positive in both the nasal swab and faecal PCR tests. A
combination of the nasal swab and faecal PCR tests detected 63.9% of all the South American camelids with
pathology that were tested.
Conclusions: The results suggest that antemortem diagnosis of Mycobacterium bovis in South American camelids
may be possible using a PCR test on clinical samples, however more work is required to determine sensitivity and
specificity, and the practicalities of applying the test in the field.
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Mycobacterium bovis infection in South American came-
lids (SAC) in Great Britain (GB) was first detected in a
llama in 1999 [1] and the number of herds affected each
year has shown an increasing trend [2]. The current ante
mortem immunological tests available to detect TB in
SACs do not have high sensitivity individually, though in
if used in combination sensitivity can be increased [3].
In GB there is no routine testing of SACs for TB and
as a consequence disease is often first detected only
when a SAC dies and it is examined post-mortem. Cases
at post-mortem examination frequently show extensive
pathology and there is good concordance between path-
ology and culture for M. bovis [4]. In some herds disease
has spread widely before detection, and losses in these
herds can be very high. On post-mortem examination* Correspondence: Kirsty.Line@ahvla.gsi.gov.uk
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article, unless otherwise stated.the characteristic gross pathology of TB in SACs can be
extensive [5] suggesting that M. bovis may be present in
nasal discharge, blood or faeces. While this could be a
source for onwards spread of infection it could also fa-
cilitate ante mortem detection of disease.
A PCR test could offer improved specificity compared
to immunological tests on blood. The calculated specifi-
city of the antibody tests was 96.7 to 97.4%, with the sensi-
tivity of the gamma interferon test specificity substantially
lower [3]. A PCR test could be used on clinical samples
from an unrestricted SAC herd, offering the possibility of
detection of disease before there were SACs submitted for
post mortem examination. A test with very high specificity
would be more acceptable to the owners of SACs.
PCR testing does not appear to have been previously ap-
plied to clinical samples from SACs but PCR testing to de-
tect members of the Mycobacterium tuberculosis complex
have been applied to clinical samples in other species
[6-10]. They have been used on human blood, sputum
and faeces to detect Mycobacterium tuberculosis [6,8,10].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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nasal mucous and milk [7,9]. A PCR test has also been
used to detect M. bovis in badger faeces and its use has
been validated by an inter-laboratory trial [11].
The potential sensitivity of a test on clinical samples
is dependent on the occurrence and quantity of the target
organism in the clinical sample tested and the sensitivity
of the test used. In the case of human blood, increasing
levels of mycobacterial DNA have been found as the clas-
sification of disease severity increased [12]. The method
of extraction at least for sputum appears to be critical to
sensitivity [13].
The Regional Laboratories of the AHVLA examine
carcases of SACs that have been euthanised as part of
the Defra TB surveillance program. This provided an op-
portunity to collect clinical samples post mortem and
examine them for M. bovis. A sensitive methodology for
mycobacterial DNA extraction from faeces and nasal
mucous using bead beating was developed and applied
to the simulated clinical samples. The objective of this
study was to determine if PCR testing using the sensitive
extraction methodology on nasal swabs and faeces or
directly on bloods could be used to detect M. bovis in
SACs with a range of M. bovis pathology.
Methods
Samples were collected from 63 SACs and all were from
herds where infection with M. bovis had been confirmed
by culture of tissues [10]. Samples were collected at four
Regional Laboratories. Shortly after delivery of the car-
case an attempt was made to collect a transthoracic car-
diac blood sample. A nasal swab was taken before the
carcase was hoisted to minimise contamination of nasal
passages by leaking gut contents. The swab was passed 5
to 7 cms into each nostril. A faeces sample was taken
from the rectum immediately on opening the carcass
using clean gloves and instruments to minimise contam-
ination. For each of the SACs sampled any pathology
typical of M. bovis infection [5] was recorded in the post
mortem report by the pathologists.
The samples were forwarded to the testing laboratory
and nasal swabs and blood samples were partially proc-
essed prior to being frozen at -80°C, along with faeces,
until DNA extraction and PCR were performed.
All the 63 SACs with samples were scored according
to a pathology scoring system. The system scored them
from no visible lesions of TB to extensive disease with
extrathoracic spread. This was achieved by interpreting
the post-mortem reports and scoring them according to
the regime in Table 1. All of the parameters for all of the
SACs were scored and the sum of the values assigned
was the overall pathology score for that SAC. This sys-
tem produced an ordinal scale with a minimum score of
0 and a potential maximum score of 12.Samples to take forward for PCR analysis were se-
lected to be representative of the full range of pathology
scores and included 8 SACs which had no grossly visible
lesions of TB (Table 2). These samples came from 44
of the 63 animals examined. Where there were more
animals available than required for testing the actual ani-
mals tested were selected randomly.
Culture for mycobacteria [14] was carried out on se-




Swabs were agitated into 0.2 ml phosphate buffered sa-
line, centrifuged for 30 seconds at 16000 g in a micro-
fuge to pellet cells, and the supernatant discarded. The
pellet was resuspended in 0.1 ml. nuclease-free water.
Samples were retained at -80°C. After thawing and the
addition of 0.9 ml nuclease-free water, the samples were
subjected to ‘bead beating’ to fully lyse cells present
using a tissue homogeniser (Precellys 24, Bertin Tech-
nologies, France) and silica beads (Lysing matrix B tubes,
MP Biomedicals, California). DNA was extracted from
the lysate using an RNA/DNA extraction kit (MagMAX
Pathogen RNA/DNA kit, Applied Biosystems, California)
and magnetic particle processor (MagMAX Express 96,
Applied Biosystems, California).
Faeces
2 g of faecal sample was first suspended in 35 ml sterile
water overnight to fully hydrate the faeces and ensure
release of bacterial organisms present. After 15 minutes
of rocking and 30 minutes to allow settling of debris, a
20 ml aliquot of the top fraction was taken and centri-
fuged at 2,500 g, for 25 minutes. The supernatant was
discarded and the pellet resuspended in 1 ml TE buffer
(pH 8.0) and subjected to ‘bead beating’ as above. DNA
was extracted as above.
Blood
A 0.5 ml aliquot of whole blood was retained for direct
DNA extraction, and the remaining blood was processed
to harvest the monocytes (buffy coat layer). The remaining
blood was centrifuged at 2500 g for 10 min to fractionate
the blood: Clear plasma (top), grey to green buffy coat
layer (middle), and concentrated red blood cells (bottom).
The plasma layer was removed and discarded. The buffy
coat layer was carefully pipetted off the into a labeled
Screw top vial. Both the whole blood and the buffy coat
layer samples were retained at -80°C until DNA extrac-
tions were performed.
Both whole blood and Buffy coat samples were DNA
extracted using a Qiagen QIAmp DNA Mini Kit, follow-
ing the manufacturer’s instructions.
Table 1 Parameters used in the pathology scoring system
Value assigned
Parameter 0 1 2 3
Lung No lesions A few scattered foci More extensive areas of caseation
but not involving whole lung lobes
Severe and extensive caseation
Lungs affected Neither lung affected One lung affected Both lungs affected
Thoracic cavity Pleurisy absent Pleurisy present
Liver No lesions Minimal lesions More extensive lesions
Mesenteric lymph nodes No lesions Lesions present
Additional tissues affected No additional tissues 1 additional tissue 2 additional tissues 3 or more additional tissues
Table 3 Results for the fourteen SACs where
mycobacterial culture was undertaken
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IS1081 – TB complex
All samples were subjected to the IS1081 Real Time PCR
to identify those positive for TB Complex DNA using a
method based on that of Taylor, et al. [15] Primers 5′ CTG
CTCTCGACGTTCATCGCCG 3′ & 5′ TGGCGGTAGCC
GTTGCGC 3′ were used with probe [HEX] ATTGGACC
GCTCATCGCTGCGTTCGC [BHQ1]. The target inser-
tion sequence has multiple copies in the genome, offering
good sensitivity.
RD4 – M. bovis
All samples positive for TB Complex IS1081 PCR were
subjected to the RD4 Real Time PCR based on that of
Taylor, et al. [15] to confirm the presence of M. bovis
DNA. Primers 5′ TGT GAA TTC ATA CAA GCC GTA
GTC G 3′ & 5′ ATG GCT ATT GAC CAG CTA AGA
TAT CCG 3′ were used with probe 5′ [CY5] -CAA
CAC TCT TGG AGT GGC CTA CAA CGG C [BHQ2]
3′. The RD4 deletion is a single target per genome and
is expected to be of a lower sensitivity than the IS1081
PCR.Table 2 Results of the nasal swab PCR, faeces PCR and a











0 8 0 0 0
1 2 0 0 0
2 2 1 1 1
3 6 1 1 1
4 5 1 3 3
5 7 2 4 5
6 3 1 2 2
7 5 3 4 5
8 1 0 1 1
9 5 5 5 5
Total 44 14 21 23The PCRs were carried out using a PCR kit (Quanti-
Tect Multiplex PCR NoRox kit, Qiagen, Germany) ac-
cording to the manufacturer’s instructions on a real time
PCR machine (Stratagene Mx3000P, Aglient Life Sci-
ences, California). Both IS1081 and RD4 PCR were run
for one cycle of 15mins at 95°C followed by 45 cycles of:
30 s at 94°C and 30 s at 60°C using HEX and CY5 probes
respectively.
In addition to the 44 SAC samples, further DNA ex-
traction control samples were used. A bovine faeces
sample was used as a negative extraction control and a
bovine faeces sample known to be positive for Mycobac-
terium avium subsp. paratuberculosis (MAP) was used
as a positive extraction control. The DNA from the lat-
ter was subjected to Real Time MAP PCR to confirm
successful DNA extraction.
The Cochran-Armitage test for a trend using statistical
analysis software (StatXact software version 8, Cytel,








0 M. bovis Negative Negative Negative
0 Negative Negative Negative Negative
0 Negative Negative Negative Negative
1 Negative Negative Negative Negative
2 M. bovis Positive Positive Positive
3 Negative Negative Negative Negative
3 M. bovis Negative Negative Negative
4 M. bovis Negative Positive Positive
5 Negative Negative Negative Negative
5 M. bovis Negative Negative Negative
5 M. bovis Positive Negative Positive
6 M. bovis Positive Positive Positive
7 M. bovis Positive Negative Positive
9 M. bovis Positive Positive Positive
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ation for the pathology scores.
Results
The positive and negative extraction control samples
were negative in the M. bovis PCR and MAP DNA was
confirmed in the positive extraction control.
Samples from one llama and 43 alpacas were selected
for DNA extraction and PCR. Forty sets of samples orig-
inated from one large outbreak with four sets of samples
from three further outbreaks. Of the 44 SACs selected 8
had no visible lesions of TB and 36 had pathology scores
between 1 and 9 on the ordinal scale (Table 2).
Some of the nasal swab samples were contaminated
with blood as a result of leakage into nasal passages prior
to samples being taken. All DNA extracts from samples
were tested by IS1081 PCR, and 14 were found to be posi-
tive (mean CT value 31.1 range 24.3 to 38.8). The same 14
were all positive using the RD4 PCR (mean CT value 31.8
range 24.9 to 39.1), confirming the presence of M. bovis.
Of the 44 DNA extracts on faeces tested, 21 were posi-
tive for IS1081 (mean CT value 30.1 range 23.1 to 37.0)
and again all 21 were confirmed as M. bovis by RD4
PCR (mean CT value 32.0 range 25.4 to 39.4).
Unfortunately suitable blood samples were only ob-
tained from 3 SACs due to the difficulties of taking
transthoracic blood samples post-mortem. The buffy
coat DNA extraction samples yielded 1 sample positive
for IS1081 of the three tested and which was also found
to be positive by RD4 PCR. Whole blood DNA extracts
did not yield any positive results.
The Cochran-Armitage test showed a highly signifi-
cant increasing trend with pathology score in the pro-
portion of positive results. The exact p-values calculated
by for the nasal swab PCR or the faecal PCR alone and
the combination of both were all <0.001.
Culture of tissue samples for mycobacteria was carried
out on fourteen of the 44 SACs tested. Of the five that
were negative on culture all were also negative in the
PCR tests. Of the nine that were positive the faecal PCR
did not detect five and the nasal swab PCR did not de-
tect four. A combination of the PCR tests did not detect
three (Table 3).
Discussion and conclusions
The results of this study suggest that PCR testing
of clinical samples from SACs may offer a route for the
ante mortem detection of M. bovis infection. As the
samples were taken post mortem these results may not
replicate those that would be obtained with true clinical
samples. More work including field validation is needed
before routine use of this test could be considered.
While more SACs were positive in the faecal PCR
problems associated with collection of the nasal swabspost mortem may have compromised the test on this
sample type. A combination of the nasal swab PCR and
faecal PCR appeared to have a marginally greater sensi-
tivity than either of the tests alone. Testing of both sam-
ple types may increase sensitivity but at increased cost.
Nasal swabs and faeces samples are relatively easy for
owners to collect though there needs to be consideration
of the possible exposure of owners to M. bovis when col-
lecting nasal swabs. Pooling of samples from multiple
SACs may potentially be a useful screening test. Too few
blood samples could be collected for any evaluation.
There is a highly significant increasing trend in the
proportion of positive results in the nasal swab and fae-
cal PCR tests with increasing pathology score. This con-
firms, as expected, that a PCR test on clinical samples
will have greatest sensitivity in SACs with more exten-
sive pathology.
The number of SACs where culture results were avail-
able was small but the results were in agreement with
the PCR results apart from three which were culture
positive and PCR negative. This finding is not unex-
pected as post mortem and culture will be more sensi-
tive than a PCR test on clinical samples.
Theoretically at least an uninfected SAC could ingest
M. bovis contained in the secretions or excretions of an
infected SAC that was in close contact. This might occur
following contamination of feed in a trough for example.
A very sensitive test might produce a positive result in
these circumstances. In this study all the culture nega-
tive SACs were negative on PCR testing. In addition the
gross pathology negative SACs which were also all nega-
tive on PCR had been housed in groups which had large
numbers of positive animals. While this is a small study
both of these findings suggest that contamination of un-
infected alpacas by infected alpacas does not generate
false positives in the PCR.
The gross pathology seen in SACs is frequently much
more extensive than that seen in other species infected
with M. bovis. This makes ante mortem detection of M.
bovis in clinical samples less likely to be useful in species
with less overt pathology. This is the most likely reason
that PCR as a diagnostic tool in other species has been
little investigated. Previous M. bovis PCR studies have
been based on correlation with skin test results [7,9], not
pathology of disease, or culture of tissue. The badger
PCR work did not investigate the pathology of the ani-
mals, but the faeces alone [11].
Since the SACs tested were a biased sample selected
to cover the range of pathology observed, it is not pos-
sible to accurately calculate a sensitivity. However, of the
36 pathology positive SACs, 23 were positive by PCR,
providing a crude sensitivity of 64%. This compares to
sensitivities of 57.7 to 69.2% for the antibody tests when
used alone [3]. The sensitivity of the gamma interferon
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ities only possible with poor specificity [3]. The PCR test
did not produce any false positive results, indicating a
specificity of 100%. This compares to specificitiy of the
antibody tests of 96.7% to 97.4% [3]. The PCR test offers
the potential for a high specificity test with comparable
sensitivity to the antibody tests.
More work is needed to demonstrate that it is prac-
tical to collect the clinical samples in the field. Testing
of true ante mortem clinical samples both in infected
herds and in herds with a low risk of TB are required to
generate more data on sensitivity and specificity.
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